glp-1 drugs and muscle loss Most of the “muscle loss” blamed on wasn't all muscle. DXA scans can't reliably distinguish from organ tissue, glycogen, water; so reductions in liver fat and other compartments Do GLP-1 Drugs Cause Too

Additionally, in one of the earliest studies done on ipamorelin (published in 1999), researchers found that ipamorelin administration actually appeared to increase the length of long bones in rats particularly the tibia, a leg bone [6]

(Frear and Swanson, 1970)]

10.1016/S0891-5849(96)00240-7 Free Radic

Any off-label use should comply with applicable laws and be conducted under appropriate medical supervision

Many of these patients have filed lawsuits that have been combined into a federal group filing against GLP-1 makers like Novo Nordisk and Eli Lilly

Another possible intervention is physical exercise, given its metabolic benefits, its role in maintaining homeostasis, and its positive impact on cardiorespiratory fitness (Qiu et al., 2023)